Dr. Nadine Abdallah, MD

Dr. Abdallah practices at Mayo Clinic Breast Diagnostic Clinic in Rochester, Minnesota.

Dr. Abdallah's NPI, 1093169112, was assigned on April 14, 2016. Dr. Abdallah holds Minnesota license 66871.

Dr. Abdallah's primary practice is Mayo Clinic Breast Diagnostic Clinic, at 200 First Street SW, Rochester, MN 55905. The practice phone is (507) 284-5968.

Dr. Abdallah's primary practice is Mayo Clinic Breast Diagnostic Clinic in Rochester, Minnesota. Dr. Abdallah is also affiliated with Mayo Clinic Hospital, Saint Marys Campus. The medical group on file is Mayo Clinic. Dmand AI also links Dr. Abdallah to 2 more hospitals, 1 clinical lab and 1 hospice, each named with a free account. Dr. Abdallah's employer is on file too: a breast imaging center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abdallah practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Abdallah's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dr. Abdallah is licensed in Minnesota.

CMS data shows 139 Medicare services from Dr. Abdallah across 5 procedure codes in 2024, for 136 Medicare patients. Medicare paid $12,646 for them. Every service was in an office.

CMS counts 136 Medicare patients who saw Dr. Abdallah in 2024. The largest group is 65 to 74, with 66 patients. 65% of them have high blood pressure, and 62% have high cholesterol. Their average risk score is 1.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Abdallah's median patient age at 70, with 40% women.

In 2024, Dr. Abdallah wrote 200 Medicare Part D claims for 48 patients. 79% of them were for generic drugs. CMS names the drug for 108 of them, across 5 drugs with 11 or more claims each, at $491,384 in total drug cost. In 2023, CMS named 62 claims across 4 drugs.

Dr. Abdallah accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Abdallah as offering telehealth.

Dmand AI links 46 papers to Dr. Abdallah, published from 2018 to 2025. 2024 was the busiest year, with 8. The most frequent topics are Multiple Myeloma, Antineoplastic Combined Chemotherapy Protocols and Antibodies, Monoclonal. Dr. Abdallah has published most often in Blood Cancer J. Dr. Abdallah's most frequent co-authors are Angela Dispenzieri, MD, Rahma M. Warsame, MD and Morie A. Gertz, MD.

CMS Open Payments shows 6 general payments to Dr. Abdallah from 4 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 90% of the total. Sanofi and Genzyme US Companies paid the most, $1,610.